Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer.

Black JL, Harrell JC, Leisner TM, Fellmeth MJ, George SD, Reinhold D, Baker NM, Jones CD, Der CJ, Perou CM, Parise LV.

Breast Cancer Res Treat. 2015 Jul;152(2):337-46. doi: 10.1007/s10549-015-3458-4. Epub 2015 Jun 24.

PMID:
26105795
2.

Potential compensation among group I PAK members in hindlimb ischemia and wound healing.

Elsherif L, Ozler M, Zayed MA, Shen JH, Chernoff J, Faber JE, Parise LV.

PLoS One. 2014 Nov 7;9(11):e112239. doi: 10.1371/journal.pone.0112239. eCollection 2014.

3.

Identification of novel integrin binding partners for calcium and integrin binding protein 1 (CIB1): structural and thermodynamic basis of CIB1 promiscuity.

Freeman TC Jr, Black JL, Bray HG, Dagliyan O, Wu YI, Tripathy A, Dokholyan NV, Leisner TM, Parise LV.

Biochemistry. 2013 Oct 8;52(40):7082-90. doi: 10.1021/bi400678y. Epub 2013 Sep 25.

4.

Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation.

Holly SP, Chang JW, Li W, Niessen S, Phillips RM, Piatt R, Black JL, Smith MC, Boulaftali Y, Weyrich AS, Bergmeier W, Cravatt BF, Parise LV.

Chem Biol. 2013 Sep 19;20(9):1125-34. doi: 10.1016/j.chembiol.2013.07.011. Epub 2013 Aug 29.

5.

A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

Desai PC, Brittain JE, Jones SK, McDonald A, Wilson DR, Dominik R, Key NS, Parise LV, Ataga KI.

Thromb Res. 2013 Sep;132(3):341-5. doi: 10.1016/j.thromres.2013.08.002. Epub 2013 Aug 8.

6.

Protein phosphatase 2A catalytic subunit α plays a MyD88-dependent, central role in the gene-specific regulation of endotoxin tolerance.

Xie L, Liu C, Wang L, Gunawardena HP, Yu Y, Du R, Taxman DJ, Dai P, Yan Z, Yu J, Holly SP, Parise LV, Wan YY, Ting JP, Chen X.

Cell Rep. 2013 Mar 28;3(3):678-88. doi: 10.1016/j.celrep.2013.01.029. Epub 2013 Feb 21.

7.

Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48.

Riazuddin S, Belyantseva IA, Giese AP, Lee K, Indzhykulian AA, Nandamuri SP, Yousaf R, Sinha GP, Lee S, Terrell D, Hegde RS, Ali RA, Anwar S, Andrade-Elizondo PB, Sirmaci A, Parise LV, Basit S, Wali A, Ayub M, Ansar M, Ahmad W, Khan SN, Akram J, Tekin M, Riazuddin S, Cook T, Buschbeck EK, Frolenkov GI, Leal SM, Friedman TB, Ahmed ZM.

Nat Genet. 2012 Nov;44(11):1265-71. doi: 10.1038/ng.2426. Epub 2012 Sep 30.

8.

CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling.

Leisner TM, Moran C, Holly SP, Parise LV.

Oncogene. 2013 Aug 22;32(34):4017-27. doi: 10.1038/onc.2012.408. Epub 2012 Sep 10.

9.

Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart.

Willis MS, Homeister JW, Rosson GB, Annayev Y, Holley D, Holly SP, Madden VJ, Godfrey V, Parise LV, Bultman SJ.

Circ Res. 2012 Aug 17;111(5):e111-22. doi: 10.1161/CIRCRESAHA.112.265587. Epub 2012 Jun 27.

10.

Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease.

Chantrathammachart P, Mackman N, Sparkenbaugh E, Wang JG, Parise LV, Kirchhofer D, Key NS, Pawlinski R.

Blood. 2012 Jul 19;120(3):636-46. doi: 10.1182/blood-2012-04-424143. Epub 2012 Jun 1.

11.

Abundance- and Activity-Based Proteomics in Platelet Biology.

Holly SP, Chen X, Parise LV.

Curr Proteomics. 2011 Oct;8(3):216-228.

12.

Big science for small cells: systems approaches for platelets.

Holly SP, Parise LV.

Curr Drug Targets. 2011 Nov;12(12):1859-70. Review.

PMID:
21718236
13.

Talin's second act-ivation: retraction.

Leisner TM, Parise LV.

Blood. 2011 Feb 3;117(5):1442-3. doi: 10.1182/blood-2010-11-317230.

14.

Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.

Williams MS, Weiss EJ, Sabatine MS, Simon DI, Bahou WF, Becker LC, Parise LV, Dauerman HL, French PA, Smyth SS, Becker RC; 2010 Platelet Colloquium Participants.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2372-84. doi: 10.1161/ATVBAHA.110.218131. Review.

15.

Tumor growth and angiogenesis is impaired in CIB1 knockout mice.

Zayed MA, Yuan W, Chalothorn D, Faber JE, Parise LV.

J Angiogenes Res. 2010 Aug 30;2:17. doi: 10.1186/2040-2384-2-17.

16.

The interaction between AID and CIB1 is nonessential for antibody gene diversification by gene conversion or class switch recombination.

Demorest ZL, MacDuff DA, Brown WL, Morham SG, Parise LV, Harris RS.

PLoS One. 2010 Jul 20;5(7):e11660. doi: 10.1371/journal.pone.0011660.

17.

CIB1 is a regulator of pathological cardiac hypertrophy.

Heineke J, Auger-Messier M, Correll RN, Xu J, Benard MJ, Yuan W, Drexler H, Parise LV, Molkentin JD.

Nat Med. 2010 Aug;16(8):872-9. doi: 10.1038/nm.2181. Epub 2010 Jul 18.

18.

Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation.

Wang Z, Holly SP, Larson MK, Liu J, Yuan W, Chrzanowska-Wodnicka M, White GC 2nd, Parise LV.

J Thromb Haemost. 2009 Apr;7(4):693-700. doi: 10.1111/j.1538-7836.2009.03289.x. Epub 2009 Jan 17.

19.
20.

The alpha4beta1 integrin in sickle cell disease.

Brittain JE, Parise LV.

Transfus Clin Biol. 2008 Feb-Mar;15(1-2):19-22. doi: 10.1016/j.tracli.2008.03.013. Epub 2008 May 23. Review.

PMID:
18501656
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk